ArticleThe Journal of infection2021
Medical features of COVID-19 and influenza infection: A comparative study in Paris, France.
Abstract readLetterComment
In one paragraph
Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Differences in clinical characteristics between coronavirus disease 2019 (COVID-19) and influenza: a systematic review and meta-analysis.NPJ primary care respiratory medicine · 2025Pooled it
- Differences of the Chest Images Between Coronavirus Disease 2019 (COVID-19) Patients and Influenza Patients: A Systematic Review and Meta-analysis.International journal of medical sciences · 2025Pooled it
- Pooled it
- Pooled it
- Burden of Neurologic Health Care and Incident Neurologic Diagnoses in the Year After COVID-19 or Influenza Hospitalization.Neurology · 2024Article
- Public voices on tie-breaking criteria and underlying values in COVID-19 triage protocols to access critical care: a scoping review.Discover health systems · 2023Article
- Herpesviridae lung reactivation and infection in patients with severe COVID-19 or influenza virus pneumonia: a comparative study.Annals of intensive care · 2022Article
- Influenza is more severe than our newest enemy (COVID-19) in hospitalized children: Experience from a tertiary center.Journal of medical virology · 2022Article
- Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022Article
- Symptom Clustering Patterns and Population Characteristics of COVID-19 Based on Text Clustering Method.Frontiers in public health · 2022Article
- Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission.Infection · 2021Article
- Pneumonia Caused by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Virus: A Multicenter Comparative Study.Open forum infectious diseases · 2021Article
- A vital sign-based prediction algorithm for differentiating COVID-19 versus seasonal influenza in hospitalized patients.NPJ digital medicine · 2021Article
- Care pathway and prioritization of rapid testing for COVID-19 in UK hospitals: a qualitative evaluation.BMC health services research · 2021Article
- Comparison of COVID-19 and influenza in adult patients: Neurological symptoms input.Journal of medical virology · 2021Article
- Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study.BMC infectious diseases · 2021Observational
- Article
Corrections and comments
- Comment on
Authors and funding
14 authors.
Hélène FauryAP-HP.Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
Camille CourboulèsAP-HP.Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
Mathilde PayenAP-HP.Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
Aude JarySorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 83 boulevard de l'hôpital, F 75013 Paris, France.
Pierre HausfaterAP-HP.Sorbonne Université, Hôpital Pitié-Salpêtrière, Service d'Accueil des Urgences and Sorbonne Universités GRC-14 BIOSFAST et INSERM UMR-S 1166, Paris, France.
CharlesEdouard LuytAP-HP.Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Médecine Intensive Réanimation, Institut de Cardiologie and Sorbonne Université, INSERM, UMRS_1166-ICAN Institut de Cardiométabolisme et Nutrition, Paris, France.
Martin DresAP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Pneumologie, Médecine intensive et Réanimation, Paris, France; Sorbonne Université, INSERM, UMRS1158 Neurophysiologie respiratoire expérimentale et clinique - Réanimation, Paris, France.
Valérie PourcherSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Maladies Infectieuses, Paris, France.
Basma AbdiSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 83 boulevard de l'hôpital, F 75013 Paris, France.
Marc WirdenSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 83 boulevard de l'hôpital, F 75013 Paris, France.
Vincent CalvezSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 83 boulevard de l'hôpital, F 75013 Paris, France.
Anne-Geneviève MarcelinSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 83 boulevard de l'hôpital, F 75013 Paris, France.
David BoutolleauSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 83 boulevard de l'hôpital, F 75013 Paris, France.
Sonia BurrelSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, 83 boulevard de l'hôpital, F 75013 Paris, France. Electronic address: sonia.burrel@aphp.fr.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
CoinfectionCOVID-19EpidemicsInfluenza, HumanOrthomyxoviridaeChinaFranceHumansParisSARS-CoV-2COVID-19InfluenzaReferences: 10Risk factorsSevere clinical forms
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.